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Abstract
Background: Our aim was to review our management of inverted papilloma (IP), perform a recurrence analysis,
and review the literature.
Methods: A retrospective analysis of 247 patients treated for an IP. Patients were grouped according to surgical
approach, tumor presentation (primary, residual and recurrence) and Krouse-stage.
Results: Recurrence was observed in 20.3%, 28.6% and 35.1% (p = 0.017) of the patients who underwent
endoscopic, external and combined surgery, respectively. Recurrences occurred more often in residual than primary
IP (36.9% vs. 22.3%, p = 0.021). Primary endoscopic surgery had a recurrence rate of 12.5%, which was comparable
to the recent literature (11.2%, 161/1433).
Conclusions: The relatively high number of recurrences in this cohort is explained by the long follow-up and
previous (incomplete) surgery in 61.5% of the cases. The inferior outcome of residual IP underscores the importance
of having a low threshold for preoperative biopsy in unilateral and atypical sinonasal disease.
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Background
Inverted papilloma (IP) is a benign tumor of the sinona-
sal cavities. It was first described by Ward more than
150 years ago as a follicular tumor involving the nasal
bones [1]. It took until 1938 for Ringertz to recognize
the characteristic endophytic growth pattern and intro-
duce the term ‘inverting papilloma’ [2]. Since then many
researchers have contributed to the extensive knowledge
we now have on IP [3].
The incidence of IP ranges from 0.2 to 0.6 people di-
agnosed per 100,000 per year. The most frequently re-
ported complaints are similar to those of sinonasal
polyps: unilateral nasal obstruction and rhinorrhea. IP is
most commonly diagnosed in the fifth and sixth decade of
life and has a predilection for males with a ratio of 3:1 [4].
The exact etiology of IP is unclear, but there are indications
that HPV infection plays a role in the progression of
inverted papilloma and confers an increased risk for recur-
rence and malignant transformation [5, 6]. The frequency
of IP in unsuspected sinonasal polyps is reported to be be-
tween 0.31 and 0.93% [7, 8].
The standard treatment has always been surgery aimed
at complete removal of the tumor. Its association with
malignancies in 5–15% is one of the distinct characteris-
tics of IP that endorses surgical treatment [9]. Other im-
portant features include its aggressive growth, that
causes adjacent bone to locally erode, and its tendency
to recur. Over the last decades endoscopic surgery has
become the gold standard for the treatment of IP with
many studies showing significantly better treatment out-
come in patients treated endoscopically [9].
The aim of this study was to analyze the developments
in our management of IP over the last three decades, in
particular with regard to the recurrence rates and out-
comes of treatment. All surgical approaches were reviewed,
with an emphasis on endoscopic surgery. Whether the
presentation of the tumor (primary, residual or recurrent)
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before surgery in our clinic would affect the recurrence
rate also had our interest. Finally, a literature review of IP
cohort studies was performed to compare with our surgical
outcomes and recurrence rates.
Methods
The Ethics Committee of the Erasmus Medical Center, a
tertiary referral medical center, stated that ethical per-
mission was not required for this retrospective study.
We included 323 IP patients, of which 247 were in-
cluded in the recurrence analysis, between January 1983
and December 2012. All patients were obtained from
PALGA, a Dutch nationwide network and registry of
histo- and cytopathology. All cases received surgical
treatment, had a preoperative histopathological proven
diagnosis of IP, and complete clinical information. Clin-
ical data was assessed using the electronic medical re-
cords (CSC-iSOFT, Virginia, USA) and paper charts.
The IP was classified as a primary when no prior surgery
was performed and diagnosis was confirmed by a simple
biopsy. Patients with previous surgery were divided into
two groups: residual and recurrent IP. Residual IP were
defined as those who underwent functional endoscopic
surgery for reasons other than IP, which was deemed as
inadequate tumor surgery. Inverted papilloma diagnosis is
this group was unexpected at postoperative histopatho-
logical examination. Recurrent IP were defined as those
who underwent adequate tumor surgery in a different,
non-academic hospital with the preoperative suspicion or
diagnosis of IP. These patients were referred to us for revi-
sion surgery after diagnosis of a recurrence.
All patients underwent surgery by experienced head
and neck surgeons. Surgical treatment was divided into
three groups: endoscopic surgery (pure endonasal endo-
scopic approach), external surgery (e.g., Denker, lateral
rhinotomy, osteoplastic flap) and combined approaches
(endoscopic surgery combined with Caldwell-Luc). The
extent of surgery and approach were chosen based on
the perceived origin and extent of the IP. In the endo-
scopic group, we mainly performed a medial maxillect-
omy, including (at least the posterior two thirds of ) the
inferior turbinate and an ethmoidectomy. We opted for
a radical ethmoidectomy, including middle turbinate and
opening of the frontal recess, for tumors limited to the
ethmoid and/or frontal recess. For the external ap-
proach, we mainly performed a classic Denker (medial
maxillectomy via opening of the anterior wall of the
maxillary sinus, complete removal of maxillary sinus
mucosa, radical ethmoidectomy, and sphenoidectomy).
The combined approach was applied to maxillary tu-
mors originating lateral to the infraorbital nerve. A med-
ial maxillectomy was performed in all cases with the
exception of tumors limited to only the frontal sinus or
sphenoid. Complications after surgery were classified
according to the Clavien-Dindo Classification of Surgical
Complications (Table 1) [10]. All patients were followed
up by endoscopy every three months for the first two
years. After this period, patients were followed up bian-
nually for up to five years. MRI and/or biopsies were
performed when a recurrence was suspected.
A literature search was performed of EMBASE (2005,
jan – 2016, dec) using the key term ‘inverted papilloma’.
All IP case series with a minimal follow-up of 12 months,
reporting on recurrence rates per operative approach,
and published in the English language were included.
Statistical analysis
When quantitative variables were normally distributed, the
results were expressed as mean values and standard devi-
ation (SD), otherwise median and inter quartile range
(IQR). Differences between two groups were analyzed
using the t-test or the Mann-Whitney U test. Qualitative
data are reported as counts and frequencies, and differ-
ences between groups were analyzed using the chi-squared
test or Fisher’s exact test. Multivariate logistic regression
was used to investigate the association of Krouse staging,
surgical approach and presentation of tumor and the risk
of recurrence [11]. Cox regression analysis was performed
to evaluate the association between variables of the univari-
ate analysis and recurrence free survival time. Statis-
tical analysis was performed using SPSS version 21
(IBM Co., Armonk, NY, USA) and cut off point for
significance was p < 0.05.
Results
The mean age at time of diagnosis was 55.8 years (SD
13.7). The study population consisted of 245 males and 78
females (3.1, 1). Nasal obstruction was the most frequent
complaint (257 patients, 79.6%). Other complaints were
rhinorrhea (73, 22.6%), headache (38, 11.8%), epiphora (21,
6.5%) and feeling of pressure in the face or forehead (17,
5.3%). Thirty patients (9.3%) had no complaints. Preopera-
tive radiological imaging was performed with CT-scan in
201 cases (62.2%) and with MRI in 15 cases (4.6%). Both
CT and MRI were used in 62 patients (19.2%). Forty-five
patients (13.9%) underwent surgery without preoperative
radiological imaging. The left and right side of the
Table 1 Summary of Clavien-Dindo Classification of Surgical
Complications
Grade I Any deviation from normale post-operative care without
the need for treatment or interventions
Grade II Requiring pharmacological treatment or blood transfusion
Grade III Requiring surgical, endoscopic or radiological intervention
Grade IV Life-treatening complication requiring IC/ICU management
Grade V Death of a patient
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sinonasal cavity were equally involved (50.2% vs. 48.3%).
Five patients (1.5%) had bilateral involvement.
In 121 of the cases (37.5%) the inverted papilloma was
primary, in 115 cases (35.6%) residual, and in 87 cases
(26.9%) recurrent. The tumors were classified as Krouse
T1 to T4 in respectively 38 (11.8%), 148 (45.8%), 108
(33.4%) and 29 cases (9.0%). Twenty-eight IP were classi-
fied as T4 because of an associated malignancy and one
because of extrasinonasal extension. Endoscopic surgery
was performed in 107 patients (33.1%), a combined ap-
proach in 22 cases (6.8%) and an external procedure in
194 patients (60.1%).
Complications
The overall percentage of perioperative complications was
14.6% (47 cases). Most complications were Clavien-Dindo
grade I (24, 51.1%), such as sensibility disorders, periopera-
tively managed cerebrospinal fluid leakage and excessive
crustae. Ten patients (21.3%), including four wound infec-
tions, had grade II complications. Most Clavien-Dindo
grade III complications (10, 21.3%) were complaints of
epiphora after a classical Denker procedure that required a
dacrocystorhinostomy. Two patients (4.3%, grade IV) devel-
oped meningitis post-operatively and had to be admitted to
the intensive care unit. One patient died post-operatively as
a result of severe comorbidity (2.1%, grade V).
Malignancies
Thirty-one patients (9.6%) had an associated malignancy.
The malignancy occurred synchronously in 28 cases
(90.3%). They consisted of 25 squamous cell carcinomas
(89.3%), two verrucous carcinomas (7.2%), and one un-
differentiated carcinoma (3.6%). Three other cases squa-
mous cell carcinomas developed metachronously (9.7%).
Four patients (12.9%) had a carcinoma in situ. Nine
patients had tumor with T stage I (29.0%) three with II
(9.7%), three with III (9.7%) and 12 with IV (38.7%).
Three patients (9.7%) had a regional lymph node metas-
tasis and three patients (9.7%) a distant metastasis. Most
patients (80.6%) with an associated malignancy were
treated with an external approach. For patients with an
associated malignancy, the 5-year overall survival was
80.6% and the 5-year disease specific survival 87.1%.
Eight patients with an a associated malignancy (25.8%) de-
veloped a recurrent IP after initial treatment. The 5-year
recurrence free survival rate was 77.4%. During follow-up
20 patients (64.5%) remained alive with no evidence of
disease. One (3.2%) was alive with disease, eight (25.8%)
died of disease, and two (6.5%) died of other cause.
Recurrence analysis
We included a sub selection of 247 patients cohort in
our recurrence analysis. Sixty-one patient were excluded
because their follow up was <2 years. Another fifteen pa-
tients with suspected residual IP were excluded because
postoperative histopathologic examination did not con-
firm the residual IP. The median follow-up was
66.2 months (IQR 41.1–112.9). Overall recurrences oc-
curred in 74 patients (30.0%)(Table 2).
Type of surgery
Seventy-nine (32.0%) cases in our recurrence analysis
were treated with pure endonasal endoscopic surgery.
Recurrences occurred in sixteen endoscopic cases
(20.3%). Primary IP treated endoscopically recurred in
three cases (12.5%), residual IP in eight cases (25.0%)
and recurrent IP in 5 cases (21.7%). Four of fourteen pa-
tients (28.6%) treated with a combined approach devel-
oped a recurrence. The majority of the cases had an
external procedure (154, 62.3%). They developed recur-
rences in 54 cases (35.1%). This is significantly higher
than the endoscopic group (p = 0.017, OR 95 CI 2.3
[1.1–4.4]) (Table 2). Primary tumors treated externally
recurred in eighteen cases (26.5%). For residual (45.7%,
p = 0.028, OR 95% CI 2.4 [1.1–5.6]) and recurrent
(37.5%) tumors, this percentage was higher. The distri-
bution of Krouse stage was not significantly different in
these groups (Table 3).
Presentation of tumor
The risk of recurrence was significantly higher in the re-
sidual IP group than primary IP (31 [36.9%] vs 22
[23.2%], p = 0.021 OR 95% CI 2.2 [1.1–4.3]). Recurrence
occurred in 21 cases (30.9%) in the recurrent IP group.
Table 2 Multivariate analysis of recurrence rates according to surgical approach and presentation of the tumor
Endoscopic approach Combined approach External approach Total
No. of recurrences /
total no. of patients (%)
No. of recurrences /
total no. of patients (%)
No. of recurrences /
total no. of patients (%)
No. of recurrences /
total no. of patients (%)
Primary IP 3 / 24 (12.5) 1 / 3 (33.3) 18 / 68 (26.5) 22 / 95 (23.2)
Residual IP 8 / 32 (25.0) 2 / 6 (33.3) 21 / 46 (45.7)* 31 / 84 (36.9)†
Recurrent IP 5 / 23 (21.7) 1 / 5 (20.0) 15 / 40 (37.5) 21 / 68 (30.9)
Total 16 / 79 (20.3) 4 / 14 (28.6) 54 / 154 (35.1)‡ 74 / 247 (30.0)
*p = 0.021 compared to primary IP treated with external approach. † p = 0.028 compared to total primary IP. ‡ p = 0.017 compared to total endoscopic approach
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Krouse stage
Krouse stage did not influence the overall recurrence
rate significantly. Patients with Krouse stage T1-T4 IP
developed recurrences in respectively 7 (22.6%), 36
(30.5%), 25 (28.9%), and 6 (42.9%) cases.
Time to recurrence
The median time to recurrence was 20.5 months (IQR
11.8–37.5). The surgical approach and the presentation
of the tumor had no significant influence on the time to
recurrence. Table 4 gives an overview of when the recur-
rences occur during follow-up. Only forty-one (55.4%) of
all recurrences were diagnosed in the first two years of
follow-up. More than 80% (58) of all recurrences were
diagnosed within four years.
Number of recurrences
Thirty-seven (50%) of all 74 cases with a recurrence after
initial surgery in our hospital developed a second recur-
rence after revision surgery. This occurred more often in
the group of patients that underwent external surgery
than the endoscopic group (5/16 [31.3%] vs. 32/54
[59.3%], p = 0.049). Eighteen patients (24.3%) developed
a third recurrence, while six patients (8.1%) developed
even more than three recurrences during follow-up.
Literature review
A total of 64 articles IP cohort-studies between 2005 and
2016 were found, of which 23 articles with a total of 1989
patients met the inclusion criteria (Table 5) [12–34]. Their
mean follow-up was 54.5 months. Of the 1433 patients
treated endoscopically 161 (11.2%) developed a recur-
rence. Recurrence rates reported varied between 0.0% and
30.0%. Seven articles reported a total of 32 (12.3%) recur-
rences in 260 patients treated with a combined approach.
Fifty-four (18.2%) recurrences occurred in a total of 296
external procedures. Fourty-one articles did not meet the
inclusion criteria.
Discussion
We have, to our knowledge, presented the largest ever
single-center cohort of inverted papilloma patients. Our
reported recurrence rates were higher for residual and
recurrent IP than primary IP. We also confirmed super-
iority of endoscopic surgery over combined and external
approaches. Finally, we’ve shown that many recurrences
occur more than two years after initial treatment.
Thirty percent of all the patients in our recurrence
analysis developed a recurrence (Table 2). This is rela-
tively high compared to recent literature (Table 4). This
could be explained by our heterogeneous cohort with a
high number (62.3%) of external surgery. Also our rate is
based on results covering a large time period with one
third of the patients treated before the ‘endoscopic era’.
These patients account for more than half of all recur-
rences. Based on our observation, most of the recurrences
after an external approach, Denker in particular, occur in
the frontal recess and ethmoidal roof. Tumor remnants at
these areas can easily be missed or left out during such
procedures due to lack of good visualization and
Table 3 Distribution of Krouse stage per surgical approach
Krouse stage Endoscopic approach Combined approach External approach Total
no. of patients (%) no. of patients (%) no. of patients (%) no. of patients (%)
T1 15 (19.0) 0 (0.0) 13 (8.4) 28 (11.3)
T2 39 (49.4) 2 (14.3) 75 (48.7) 116 (47.0)
T3 22 (27.8) 11 (78.6) 49 (31.8) 82 (33.2)
T4 3 (3.8) 1 (7.1) 17 (11.0) 21 (8.5)
Total 79 (100.0) 14 (100.0) 154 (100.0) 247 (100.0)
Table 4 Time to recurrence
Follow-up Endoscopic approach (n = 79) Combined approach (n = 14) External approach (n = 154)
No. of recurrences /
total no. of recurrences (%)
No. of recurrences /
total no. of recurrences (%)
No. of recurrences /
total no. of recurrences (%)
< 1 year 5 / 16 (31.3) 0 / 4 (0.0) 16 / 54 (29.6)
< 2 year 11 / 16 (68.8) 3 / 4 (75.0) 27 / 54 (50.0)
< 3 year 13 / 16 (81.3) 4 / 4 (100.0) 38 / 54 (70.4)
< 4 year 13 / 16 (81.3) 44 / 54 (81.5)
< 5 year 13 / 16 (81.3) 45 / 54 (83.3)
6–10 year 16 / 16 (100.0) 51 / 54 (94.4)
> 10 year 54 / 54 (100.0)
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magnification. Nowadays, we make it a point to inspect
these areas using an endoscope and drill out as much
bone as possible. Several literature reviews on IP recur-
rences have been published between 1981 and 2009 [9, 14,
35–37]. Their average recurrence rates after endoscopic
surgery vary between 12.5% and 19.6%. This is higher
than the 11.3% in our review of more recent studies,
suggesting a global decrease in recurrence rates in
endoscopic IP surgery.
Our recurrence in the endoscopic group (20.3%) was
also higher than the average 11.2% (161/1433) in our re-
view of the recent literature (Table 5). However, primary
tumors treated by endoscopically had a similar recur-
rence rate of 12.5%. Therefore, we believe that the rela-
tively high recurrence rate is due to our high number of
residual and recurrent IP and to our long follow (me-
dian > six years). After splitting the complete endoscopic
group in a 2003–2007 (the first years of endoscopic IP
surgery in our clinic) and a 2008–2012 cohort, we also
noted a non-significant learning curve is noticed with
31.8% and 15.4% recurrences (p = 0.12) respectively.
A wide range of recurrence rates (0.0–45.0%) have
been documented after revision surgery (Table 6) [20,
26–29, 33, 38–40]. However, it is generally accepted that
it has a worse outcome than primary surgery, which is
support that functional endoscopic sinus surgery should
not be used as a diagnostic tool for unilateral sinonasal
disease (a pre-operative biopsy should). The worse out-
come of revision IP surgery has been explained due to
the increased difficulty to identify the attachment site of
the IP because of distorted anatomy and the absence of
landmarks [33, 41, 42]. Post-operative inflammation of
the remaining sinonasal mucosa could also attribute to
this due to an increased difficulty to distinguish normal
mucosa from tumor. This is most evident in patients
with a residual IP due to the relative short time between
primary and revision surgery. It could even be that in-
complete surgery has an effect on the inflammatory
Table 5 Review of inverted papilloma cohort studies per surgical approach with a minimal follow-up of 12 months (2005–2016)








No. of recurrences / %) No. of recurrences /
total no. of patients (%)
No. of recurrences /
total no. of patients (%)
Mean Low High
Poetker et al. [12] 2005 0 / 8 (0.0) 1 / 4 (25.0) 29.8 12 80
Kamel et al. [13] 2005 3 / 52 (5.8) 65 24 160
Peng et al. [14] 2006 2 / 98 (2.0) 61 24 168
Minovi et al. [15] 2006 6 / 61 (9.8) 3 / 20 (15.0) 0 / 6 (0.0) 74 12 175
Mirza et al. [16] 2007 4 / 32 (12.5) 4 / 16 (25.0) 60 12 240
Harvinder et al. [17] 2008 0 / 5 (0.0) 23 12 36
Jurado-ramos et al. [18] 2008 4 / 34 (11.8) 8 / 18 (44.4) 54.3 12 60
Durucu et al. [19] 2009 2 / 23 (8.7) 1 / 14 (7.1) 3 / 19 (15.8) 35 16 42
Sham et al. [20] 2009 12 / 40 (30.0) 6 / 16 (37.5) 84 24 216
Rutherford et al. [21] 2010 0 / 2 (0.0) 19 15 24
Giotakis et al. [22] 2010 5 / 39 (12.8) 11 / 25 (44.0) 91 36 146
Gras-Cabrerizo et al. [23] 2010 10 / 57 (17.5) 7 / 22 (31.8) 12
Pagella et al. [24] 2011 1 / 20 (5.0) 50 24 87
Dragonetti et al. [25] 2011 5 / 84 (6.0) 39 13 97
Lombardi et al. [26] 2011 12 / 198 (6.1) 0 / 14 (0.0) 53.8 24 192
Kim et al. [27] 2012 64 / 372 (17.2) 17 / 144 (11.8) 10 / 62 (16.1) 41 12
Pagella et al. [28] 2014 1 / 73 (1.4) 58 18 138
Sciaretta et al. [29] 2014 7 / 103 (6.8) 57.7 24 167
Gu et al. [30] 2014 1 / 7 (14.3) 3 / 14 (21.4) 65 36 144
Erbek [31] 2015 0 / 8 (0.0) 30.8 12 60
Hong [32] 2015 0 / 6 (0.0) 3 / 25 (12.0) 55.6 36 93
Adriaensen [33] 2016 15 / 121 (12.4) 7 / 39 (17.9) 12 139
Healy [34] 2016 9 / 88 (10.2) 97.2 36
Total 161 / 1433 (11.2) 32 / 260 (12.3) 54 / 296 (18.2) 54.5
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pathway of the etiology and progression of IP, possibly
explaining multi-centered recurrent IP.
Many articles claim that the majority of recurrences
after IP-surgery occur in the first two years [20, 43].
Sham et al. published a detailed data of time to recur-
rences of a group of 56 patients, which supported this
statement [20]. This was however not the case in our
larger cohort: only 55.4% of all recurrences occurred in
the first two years (Table 4). This percentage was slightly
higher (68.8%) in patient treated endoscopically. A
follow-up of three years after endoscopic surgery and
four years for all cases was needed to diagnose >80% of
the recurrences. A multi-center study has also shown a
significant difference in recurrence rate between patients
with a follow-up longer and shorter than three years
(26.1 vs. 8.5%) [27]. Therefore, our department supports
suggestions by Suh and Adriaensen to perform a long or
even life-time clinical follow-up [33, 43].
Conclusion
The recurrence rate of residual tumors is significantly
higher than primary tumors. Therefore clinicians should
have a low threshold for suspecting IP and when uncertain
first take a biopsy. Furthermore, given the mean time to
recurrence and the rate of late recurrences a long follow-
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